🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/10/2009 | 8,16 | 8,16 | 8,01 | 8,05 | -1,83% | 1,83% | 67.379 |
| 15/10/2009 | 8,20 | 8,23 | 8,08 | 8,20 | -0,91% | 1,83% | 101.283 |
| 14/10/2009 | 8,27 | 8,27 | 8,12 | 8,27 | +0,91% | 1,81% | 91.024 |
| 13/10/2009 | 8,23 | 8,31 | 7,97 | 8,20 | -0,46% | 4,09% | 93.321 |
| 12/10/2009 | 8,23 | 8,27 | 8,16 | 8,23 | +1,85% | 1,36% | 46.460 |
| 09/10/2009 | 7,97 | 8,08 | 7,97 | 8,08 | +1,89% | 1,41% | 70.746 |
| 08/10/2009 | 8,01 | 8,20 | 7,90 | 7,94 | -0,47% | 3,74% | 126.236 |
| 07/10/2009 | 8,05 | 8,23 | 7,97 | 7,97 | -2,29% | 3,26% | 144.911 |
| 06/10/2009 | 8,23 | 8,23 | 8,05 | 8,16 | +0,00% | 2,27% | 148.010 |
| 05/10/2009 | 8,27 | 8,38 | 8,05 | 8,16 | -0,91% | 4,07% | 167.674 |
| 02/10/2009 | 8,16 | 8,23 | 7,94 | 8,23 | +0,00% | 3,67% | 249.213 |
| 01/10/2009 | 8,57 | 8,61 | 8,20 | 8,23 | -4,76% | 4,80% | 174.887 |
| 30/09/2009 | 8,65 | 8,83 | 8,46 | 8,65 | -0,43% | 4,33% | 311.730 |
| 29/09/2009 | 9,02 | 9,02 | 8,68 | 8,68 | -3,33% | 3,73% | 93.027 |
| 28/09/2009 | 8,98 | 9,17 | 8,80 | 8,98 | +2,56% | 4,17% | 177.212 |
| 25/09/2009 | 8,80 | 8,91 | 8,61 | 8,76 | -0,85% | 3,40% | 81.780 |
| 24/09/2009 | 9,13 | 9,13 | 8,80 | 8,83 | -2,48% | 3,69% | 168.849 |
| 23/09/2009 | 8,95 | 9,17 | 8,87 | 9,06 | +1,68% | 3,35% | 192.734 |
| 22/09/2009 | 9,32 | 9,39 | 8,87 | 8,91 | -4,03% | 5,62% | 176.063 |
| 21/09/2009 | 9,36 | 9,39 | 9,17 | 9,28 | -0,40% | 2,40% | 163.933 |
| 18/09/2009 | 9,17 | 9,32 | 8,98 | 9,32 | +2,05% | 3,67% | 242.053 |
| 17/09/2009 | 8,95 | 9,13 | 8,87 | 9,13 | +2,09% | 2,93% | 170.292 |
| 16/09/2009 | 8,91 | 8,98 | 8,76 | 8,95 | +0,84% | 2,52% | 161.182 |
| 15/09/2009 | 8,57 | 8,91 | 8,27 | 8,87 | +3,49% | 7,42% | 334.439 |
| 14/09/2009 | 9,06 | 9,06 | 8,42 | 8,57 | -5,76% | 7,02% | 349.908 |
| 11/09/2009 | 9,06 | 9,25 | 8,98 | 9,10 | +0,00% | 2,89% | 88.218 |
| 10/09/2009 | 8,98 | 9,25 | 8,76 | 9,10 | +1,25% | 5,42% | 325.836 |
| 09/09/2009 | 9,77 | 9,77 | 8,87 | 8,98 | -4,00% | 9,20% | 312.986 |
| 08/09/2009 | 8,91 | 9,58 | 8,83 | 9,36 | +5,49% | 8,40% | 599.656 |
| 04/09/2009 | 8,65 | 8,87 | 8,53 | 8,87 | +2,60% | 3,90% | 137.270 |